Biofrontera AG (B8F):企業の財務・戦略的SWOT分析

◆英語タイトル:Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH22166FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Biofrontera AG (B8F) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and markets dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED, Xepi, Aktipak and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic keratosis. Biofrontera’s BF-RhodoLED is a lamp used for photodynamic therapy with LEDs emitting red light. Belixos is a cosmetic product,indicated for regenerative care of reddened and inflamed skin. Its Belixos line of products include Belixos creme, Belixos liquid, Belixos gel, and Belixos protect. The company distributes its products through pharmaceutical wholesalers and licensing partners. Biofrontera is headquartered in Leverkusen, Germany.

Biofrontera AG Key Recent Developments

Jul 23,2020: Supervisory Board of Biofrontera renews management board appointment
May 19,2020: Biofrontera : Biofrontera reports Q1 2020 financial results
May 13,2020: Biofrontera AG: Biofrontera dismisses case against Dusa Pharmaceuticals in California state court
Apr 20,2020: Biofrontera reports full year 2019 financial results
Apr 17,2020: Biofrontera reports preliminary unaudited sales revenue for the first three months of 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Biofrontera AG – Key Facts
Biofrontera AG – Key Employees
Biofrontera AG – Key Employee Biographies
Biofrontera AG – Major Products and Services
Biofrontera AG – History
Biofrontera AG – Company Statement
Biofrontera AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Biofrontera AG – Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other regions
Performance
Geographical Segment: The US
Performance
R&D Overview
Biofrontera AG – SWOT Analysis
SWOT Analysis – Overview
Biofrontera AG – Strengths
Biofrontera AG – Weaknesses
Biofrontera AG – Opportunities
Biofrontera AG – Threats
Biofrontera AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Biofrontera AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 23, 2020: Supervisory Board of Biofrontera renews management board appointment
May 19, 2020: Biofrontera : Biofrontera reports Q1 2020 financial results
May 13, 2020: Biofrontera AG: Biofrontera dismisses case against Dusa Pharmaceuticals in California state court
Apr 20, 2020: Biofrontera reports full year 2019 financial results
Apr 17, 2020: Biofrontera reports preliminary unaudited sales revenue for the first three months of 2020
Jan 31, 2020: Organizational restructuring of Biofrontera and resignation of chief commercial officer Christoph Dünwald
Jan 06, 2020: Biofrontera strengthens commercial focus with reorganization of its US business
Dec 13, 2019: Biofrontera: Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera
Nov 19, 2019: Biofrontera reports third quarter 2019 financial results and revises guidance
Aug 27, 2019: Biofrontera shows robust growth during first six months of 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Biofrontera AG, Key Facts
Biofrontera AG, Key Employees
Biofrontera AG, Key Employee Biographies
Biofrontera AG, Major Products and Services
Biofrontera AG, History
Biofrontera AG, Subsidiaries
Biofrontera AG, Key Competitors
Biofrontera AG, Ratios based on current share price
Biofrontera AG, Annual Ratios
Biofrontera AG, Annual Ratios (Cont...1)
Biofrontera AG, Interim Ratios
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Biofrontera AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Biofrontera AG (B8F):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Air Transport Services Group, Inc.:戦略・SWOT・企業財務分析
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MedX Health Corp (MDX):医療機器:M&Aディール及び事業提携情報
    Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and …
  • RedHill Biopharma Ltd (RDHL):企業の財務・戦略的SWOT分析
    RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PT PLN (Persero):企業の発電所・SWOT分析2018
    PT PLN (Persero) - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • TeaM Energy Corp:企業の戦略的SWOT分析
    TeaM Energy Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Freehold Royalties Ltd (FRU):企業の財務・戦略的SWOT分析
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. Its oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provides horizon …
  • SimCorp AS (SIM):企業の財務・戦略的SWOT分析
    SimCorp AS (SIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Setpoint Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary SetPoint Medical Inc (SetPoint Medical) is a clinical-stage biomedical technology company that develops bioelectronic therapies for the treatment of inflammatory autoimmune diseases. The company develops a new bioelectronic medicine platform, which induces the vagus nerve to activate the bod …
  • Siam Food Products PCL:企業の戦略・SWOT・財務情報
    Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report Summary Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vyriad Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vyriad Inc (Vyriad), formerly Omnis Pharma Inc is a clinical stage bio-pharmaceutical company that develops viral-based novel oncolytic therapies for the treatment of cancer. The company’s pipeline products include various engineered viruses in phase 1 for the treatment of non small cell lun …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Siemens Medical Solutions USA Inc:医療機器:M&Aディール及び事業提携情報
    Summary Siemens Medical Solutions USA Inc (Siemens Medical USA), a subsidiary of Siemens Healthcare GmbH is a medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. The company offers products in the areas of medical imagi …
  • Torm Plc (TRMD A):石油・ガス:M&Aディール及び事業提携情報
    Summary Torm Plc (Torm) is a shipping company serving the oil and gas sector. It offers a range of transportation services through its affiliated companies. The company undertakes transportation of refined oil products such as gasoline, jet fuel, naphtha, gas oil and fuel oil through its product tan …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • DIRECT Pojistovna, a.s.:企業の戦略・SWOT・財務分析
    DIRECT Pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report Summary DIRECT Pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aura Light International AB:企業の戦略的SWOT分析
    Aura Light International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Laboratory Corp of America Holdings (LH):医療機器:M&Aディール及び事業提携情報
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • Decas Cranberry Products, Inc.:企業の戦略・SWOT・財務情報
    Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Business Development Bank Of Canada:企業の戦略・SWOT・財務分析
    Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report Summary Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆